Aesthetic and Functional Self-Assessment Following Rhinoseptoplasty in Patients With Unilateral Cleft Lip and Palate

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-30
SponsorUniversity Hospital, Montpellier

About this trial

Secondary rhino-septoplasty in unilateral cleft lip and palate is the treatment of choice for the correction of aesthetic deformities and the functional impact on ventilation nasal. It remains a difficult treatment. It can be proposed at the end of growth or from the age of 10, depending on nasal obstruction and the severity of the deformity.

The CLEFT-Q questionnaire, validated in 2017, has not yet been widely used in studies. The NOSE questionnaire is an older functional questionnaire that is complementary to the CLEFT-Q.

Cleft lip and palate are rare diseases, accounting for around 30% of all facial clefts, which occur at a rate of 1/750 births in Europe. Deformation of the nose and nasal septum is constant, and more or less severe in unilateral forms.

In the absence of rhino-septoplasty performed during primary cleft repair surgery, deformities persist in children and adolescents. There is a significant aesthetic impact in children, which generally increases in adolescents. The problem of nasal obstruction causes functional discomfort that can be disabling. Open rhino-septoplasty is a standard procedure and is proposed as a secondary treatment in this population . It is indicated during growth in cases of nasal obstruction, or as a function of aesthetic demands.

The hypothesis is that secondary rhino-septoplasty gives long-term satisfaction in patients in terms of aesthetics and respiratory function. The originality of this study lies in the use of the recently validated CLEFT-Q questionnaire to assess the aesthetic and functional satisfaction of patients in adulthood after secondary rhino-septoplasty performed in childhood or adolescence. This long-term follow-up will enable us to assess the stability of aesthetic and functional results.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Unilateral cleft lip and palate patients

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Mailing and completing CLEFT-Q and NOSE questionnaires

    Other intervention

    Mailing and completing CLEFT-Q and NOSE questionnaires

Treatment groups

80 Participants
are divided into 1 treatment group
Group A: Group of cleft lip and palate patients who underwent rhinoseptoplasty in childhood or adolescence.1 intervention

Trial outcomes

Primary outcomes

1

Nasal Obstruction and Septoplasty Effectiveness (NOSE) Scale

The Nasal Obstruction and Septoplasty Effectiveness Scale (NOSE) consists of 5 items with 5 modalities (from 0 to 4) with higher scores indicating more severe symptoms : nasal congestion, nasal obstruction, difficulty breathing through the nose, sleep disturbance and breathing difficulties during exercise.

Time frame
At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)
2

CLEFT-Q nose appearance

A raw score is first calculated as the sum of the scale items, then rescaled from a conversion table into a score from 0 (worst) to 100 (best).

Time frame
At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)
3

CLEFT-Q nostrils appearance

A raw score is first calculated as the sum of the scale items, then rescaled from a conversion table into a score from 0 (worst) to 100 (best).

Time frame
At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)
4

CLEFT-Q face appearance

A raw score is first calculated as the sum of the scale items, then rescaled from a conversion table into a score from 0 (worst) to 100 (best).

Time frame
At inclusion (i.e. 3 to 20 years after surgery, according to inclusion criteria)

Secondary outcomes

1

Asher Mc Dade Score

The aesthetic result is assessed on the basis of photographs (from the medical file) of the face, profile and lower view of the face before/after surgery, using the Asher-McDade method (score from 3 : best appearance to 15 : worst appearance)

Time frame
At least 6 months after surgery
2

Surgical complications according to the Clavien Dindo classification

The Clavien-Dindo classification ranges from Grade 1 (minor deviation from normal recovery without pharmacological treatment) to Grade 5 (death). Grade 2 involves complications requiring drugs like antibiotics or blood transfusions. Grade 3 includes complications requiring surgical, endoscopic, or radiological intervention (IIIa without general anesthesia, IIIb with). Grade 4 refers to life-threatening complications needing ICU care (IVa single organ failure, IVb multi-organ). This system standardizes reporting and allows comparison of surgical outcomes.

Time frame
few days after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.